Clinical Trial 44823

Birmingham, AL 35244


Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

Topical roflumilast cream for patients with Chronic Plaque Psoriasis involving up to 25% total Body Surface Area. Study medication will be applied by the qualifying subjects topically once daily for 52 weeks at home. 

  1. Males and females ages 18 years and older
  2. Subjects with chronic plaque psoriasis
  3. Psoriasis must involve over 25% of body

Qualified Participants May Receive:

  1. $800 in compensation for participating 
  2. Free transportation reimbursement (Parking or Uber)
  3. Treatment at no cost at all 

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.